Colgate-Palmolive (CL) director Christopher Boerner submits initial Form 3

Rhea-AI Filing Summary

Colgate-Palmolive Company director Christopher S. Boerner has filed an initial Form 3 insider ownership report. The summarized data shows no reported buy or sell transactions, no derivative exercises, and no gift, tax, or restructuring entries in this filing excerpt.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BOERNER CHRISTOPHER S.

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/15/2026

3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Kristine Hutchinson, Attorney-in-Fact	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Christopher S. Boerner Form 3 filing for CL show?

The Form 3 for Colgate-Palmolive’s Christopher S. Boerner reports his status as a director. The summarized data shows no buy or sell transactions, no derivative activity, and no reported gifts or restructurings in this excerpt of the filing.

Did Christopher S. Boerner buy or sell Colgate-Palmolive (CL) shares in this Form 3?

No transactions are shown in this Form 3 summary. BuyCount, sellCount, exerciseCount, giftCount, and taxWithholdingCount are all zero, indicating no reported purchases, sales, or other share movements in the provided data.

Does the Colgate-Palmolive (CL) Form 3 show any derivative securities for Christopher S. Boerner?

The derivative summary in this Form 3 is empty, and derivativeTransactionCount is zero. This indicates no listed options, warrants, or other derivative positions or transactions for Christopher S. Boerner in the provided excerpt.

What insider role does Christopher S. Boerner have at Colgate-Palmolive (CL)?

The Form 3 identifies Christopher S. Boerner as a director of Colgate-Palmolive Company. He is not reported as an officer or ten percent owner in the summarized role data from this filing.

Does the Christopher S. Boerner Form 3 for CL indicate any net buying or selling direction?

No, the transaction summary shows netBuySellShares at zero and netBuySellDirection marked neutral. This reflects the absence of any reported purchases or sales in the Form 3 data provided.